Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Effectiveness of daratumumab plus bortezomib, lenalidomide, and dexamethasone (DVRd) versus VRd for transplant-eligible newly diagnosed multiple myeloma.
Journal: Future oncology (London, England)
Published: July 14, 2026
Do Patients with Antiphospholipid Syndrome Present with More Significant Venous Thromboembolic Clot Burden? A Retrospective Single-Center Study.
Journal: Hematology reports
Published: January 28, 2026
Real-World Outcomes of Sequential BCMA-directed therapies in Relapsed Refractory Multiple Myeloma After Belantamab Exposure.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 07, 2025
Pelvic Gastrointestinal Stromal Tumor (GIST) Mimicking Ovarian Cancer in a Kidney-Liver Transplant Recipient Under Chronic Immunosuppression.
Journal: Case reports in oncological medicine
Published: April 05, 2025
CGE25-112: Analyzing the Prognostic Significance of Common Mutations in Pancreatic Cancer (PC) via Next Generation Sequencing (NGS).
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 28, 2025
A Novel Therapeutic Strategy for Central Nervous System Lymphoma: Integrating Chimeric Antigen Receptor T-Cell Therapy and Gamma Knife Radiation.
Journal: Journal of hematology
Published: January 16, 2025
A Case of Fulminant Cerebral Edema Leading to Death After Chimeric Antigen Receptor T-Cell Therapy.
Journal: Journal of hematology
Published: October 10, 2024
A real-world experience of efficacy and safety of belantamab mafodotin in relapsed refractory multiple myeloma.
Journal: Blood cancer journal
Published: October 08, 2024
Showing 1-10 of 10
Last Updated: 09/26/2026